The FDA has proposed to allow drug and medical-device manufacturers to promote the unapproved use of their products through “truthful and non-misleading” medical journal articles. The FDA has issued preliminary guidelines for drug companies to distribute medical journal articles to doctors on the “off-label” uses of their FDA-approved drugs. While companies are not allowed to market drugs for off-label uses, doctors are free to prescribe them for unapproved therapies.